Type 2 diabetes in youth from the Western Pacific region: glycaemic control, diabetes care and complications

被引:47
作者
Eppens, Maike C.
Craig, Maria E.
Jones, Timothy W.
Silink, Martin
Ong, Stephanie
Ping, Yeo Jing
机构
[1] Childrens Hosp Westmead, Sydney, NSW, Australia
[2] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia
[3] Leiden Univ, NL-2300 RA Leiden, Netherlands
[4] St George Hosp, Dept Paediat, Kogarah, NSW, Australia
[5] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia
[6] Princess Margaret Hosp Children, Dept Endocrinol & Diabet, Perth, WA, Australia
[7] Univ Western Australia, Ctr Child Hlth Res, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia
[8] NovoNordisk Asia Pacific Pty Ltd, Singapore, Singapore
关键词
HbA(1c); hypertension; microalbuminuria; type; 2; diabetes; youth;
D O I
10.1185/030079906X104795
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To describe the glycaemic control, diabetes care and prevalence of complications in youth with type 2 diabetes from the Western Pacific Region. Research design and methods: Cross-sectional, clinic-based audit of 331 patients aged < 18 years from 56 centres in Australia, China-Beijing, China-Shanghai, China-Hong Kong, Indonesia, Japan, South Korea, Malaysia, Philippines, Singapore, Taiwan and Thailand. Clinical and management data were recorded along with glycated haemoglobin (HbA(1c)), lipids and complication rates. Main outcome measures: Glycaemic control, complications, diabetes management. Results: Median age was 14.9 years (interquartile range 13.2-16.4 years) and median diabetes duration 2.3 years (1.4-3.6 years). Median HbA(1c) was 7% (5.9-9.9%) and HbA(1c) was > 7.5% in 40% of patients. In multiple regression analysis, glycaemic control varied significantly between countries (p = 0.02); higher HbA1c was associated with fewer home blood glucose measurements (p = 0.005) and higher insulin dose/kg (p < 0.0001). Blood glucose monitoring was performed by 65% of patients (range 33-96% by country). In 25% of patients, management consisted of diet alone or no treatment (range 0-53% by country); oral anti-diabetic drugs alone were used in 49%, insulin alone in 11% and both in 15%. Microalbuminuria was found in 8% and hypertension in 24%. The risk of hypertension increased with higher BMI (OR 1.16, 95% CI 1.09-1.24, p < 0.0001); antihypertensive agents were used in 4% of patients. Conclusions: The management of type 2 diabetes in youth from the Western Pacific Region varies widely. Hypertension and microalbuminuria were frequent, but not commonly treated. Further investigation into the natural history and risk factors for complications in youth with type 2 diabetes is required to assist in developing evidence based management guidelines.
引用
收藏
页码:1013 / 1020
页数:8
相关论文
共 41 条
[1]   Type 2 diabetes in the young: The evolving epidemic - The International Diabetes Federation Consensus Workshop [J].
Alberti, G ;
Zimmet, P ;
Shaw, J ;
Bloomgarden, Z ;
Kaufman, F ;
Silink, M .
DIABETES CARE, 2004, 27 (07) :1798-1811
[2]  
Australasian Paediatric Endocrine Group Department of Health and Ageing National Health and Medical Research Council (NHMRC), 2005, CLIN PRACT GUID TYP
[3]  
Aylin P, 2005, BRIT MED J, V331, P1167
[4]   Efficacy and safety of hypoglycemic drugs in children with type 2 diabetes mellitus [J].
Benavides, S ;
Striet, J ;
Germak, J ;
Nahata, MC .
PHARMACOTHERAPY, 2005, 25 (06) :803-809
[5]   The status of diabetes control in Asia - a cross-sectional survey of 24 317 patients with diabetes mellitus in 1998 [J].
Chuang, LM ;
Tsai, ST ;
Huang, BY ;
Tai, TY .
DIABETIC MEDICINE, 2002, 19 (12) :978-985
[6]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[7]   Establishing a standard definition for child overweight and obesity worldwide: international survey [J].
Cole, TJ ;
Bellizzi, MC ;
Flegal, KM ;
Dietz, WH .
BMJ-BRITISH MEDICAL JOURNAL, 2000, 320 (7244) :1240-1243
[8]   Predictors of glycaemic control and hypoglycaemia in children and adolescents with type 1 diabetes from NSW and the ACT [J].
Craig, ME ;
Handelsman, P ;
Donaghue, KC ;
Chan, A ;
Blades, B ;
Laina, R ;
Bradford, D ;
Middlehurst, A ;
Ambler, G ;
Verge, CF ;
Crock, P ;
Moore, P ;
Silink, M .
MEDICAL JOURNAL OF AUSTRALIA, 2002, 177 (05) :235-238
[9]   Prevalence of diabetes complications 6 years after diagnosis in an incident cohort of childhood diabetes [J].
Donaghue, KC ;
Craig, ME ;
Chan, AKF ;
Fairchild, JM ;
Cusumano, JM ;
Verge, CF ;
Crock, PA ;
Hing, SJ ;
Howard, NJ ;
Silink, M .
DIABETIC MEDICINE, 2005, 22 (06) :711-718
[10]   Glycated hemoglobin and related factors in diabetic children and adolescents under 18 years of age: A Belgian experience [J].
Dorchy, H ;
Roggemans, MP ;
Willems, D .
DIABETES CARE, 1997, 20 (01) :2-6